Botox and Trulicity are two well-known medications included in the next round of Medicare price negotiations scheduled for this year.
This will be the third round of price negotiations between Medicare and pharmaceutical manufacturers.
Botox and 14 Other Drugs to Be Negotiated by Medicare This Year
Fifteen of the most expensive medications in the Medicare program are slated for price negotiations in this round, bringing the total to 40.
Pharmacies often have facilities to distribute medication. Kirk Fisher/Shutterstock
Lawrence Wilson
Senior Reporter
Lawrence Wilson covers healthcare and politics.
